Aerpio Pharmaceuticals Inc (NASDAQ:ARPO) Sellers Decreased Their Shorts By 8.15%

It was registered a decrease on Aerpio Pharmaceuticals Inc (NASDAQ:ARPO)’s shares shorted with 8.15%. It was issued in January by FINRA the 12,400 shares shorted on ARPO. The down change of 8.15% from 13,500 shares was reported. Former ARPO’s position will need 0 days to restore. It has 78,900 average volume. Aerpio Pharmaceuticals Inc’s shares shorted float is 0.06%.

ARPO hit $3 during the last trading session after $0.605 change.Aerpio Pharmaceuticals, Inc. has 257,155 shares volume, 231.74% up from normal. ARPO is downtrending and has moved 64.37% since January 13, 2018. The stock underperformed the S&P500 by 64.37%.

Aerpio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for ocular diseases.The company has $121.74 million market cap. The company's lead product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy.Last it reported negative earnings. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.